| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.7M | -15.0% | +0.8% |
| R&D Expense | $40.0M | +8.0% | +11.2% |
| SG&A Expense | $11.1M | +5.5% | +9.6% |
| Operating Income | -$46.4M | -10.4% | -12.0% |
| Pre-tax Income | -$39.3M | -13.7% | -17.0% |
| Income Tax | $0 | -100.0% | +100.0% |
| Net Income | -$39.3M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $113.7M | -32.5% | -13.3% |
| Short-term Investments | $462.4M | +15.0% | +37.0% |
| Current Assets | $586.4M | -2.7% | +23.0% |
| Total Assets | $701.7M | -2.3% | +16.2% |
| Current Liabilities | $44.9M | +26.6% | +0.8% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $94.6M | — | — |
| Capital Expenditures | $1.4M | — | — |
| Investing Cash Flow | -$98.1M | — | — |
| Financing Cash Flow | $20.0M | — | — |
| Free Cash Flow | $93.2M | — | — |
| -13.1% |
| -18.5% |
| EPS (Basic) | -$0.62 | -12.7% | -14.8% |
| EPS (Diluted) | -$0.62 | -12.7% | -14.8% |
| $56.3M |
| +12.5% |
| -21.8% |
| Stockholders' Equity | $645.4M | -3.4% | +21.3% |